Since VEGF is a prerequisite for tumor invasion and its expression may be through either COX-2 dependent or independent pathway (20), the further studies are still deserved to validate VEGF as a target responsible for the conflicting results at the higher dose. This evidence concerns the gene PTGS2 and neoplasm.